From Dependence to Autonomy: Advanced Parkinson’s Responds to Regenerative Therapy – A Clinical Success Story

Written by Dra. María de los Ángeles López

“I can now easily remember the names of my loved ones, I cook, and I’ve returned to a normal life. Before, I couldn’t sit for more than three minutes; now I can sit for hours,”
said a 57-year-old patient treated at Genoma Health, who experienced remarkable functional recovery after receiving only two sessions in a relatively short period of time of an innovative regenerative therapy based on genetically engineered peptides.

The patient was diagnosed with Parkinson’s disease that had been present for more than eight years, aggravated by a cerebrovascular accident (CVA) that occurred a year earlier. She has a history of controlled high blood pressure. At the time of her initial evaluation at Genoma Health, she presented with severe tremor at rest, marked stiffness in the neck, a tremulous voice, difficulty sitting for more than a few minutes, and required a walker to get around. Although she maintained sphincter control, her limited mobility prevented her from reaching the bathroom independently.

In addition, she experienced cognitive difficulties that compromised her immediate memory and orientation.

Given this clinical picture, Genoma Health indicated regenerative therapy with highly specific genetically engineered peptides, designed to modulate neurodegenerative mechanisms and promote the progressive restoration of motor and cognitive functions. This biotechnological strategy is part of the center’s personalized and comprehensive approach to the treatment of neurodegenerative diseases. Since starting treatment, the patient has shown progressive and sustained improvements in several functional aspects, suggesting ongoing favorable progress:

• She is beginning to ambulate without the need for a walker in most situations

• Her resting tremor has decreased significantly

• Her voice has become more stable, with the disappearance of vocal tremor

• Her neck stiffness has significantly subsided

• She currently tolerates long periods of sitting without discomfort

• Gradual improvement in memory and orientation has been observed

• She has resumed household activities with greater independence

This clinical case demonstrates the positive impact of regenerative therapies applied at Genoma Health in patients with advanced Parkinson’s disease, even in complex clinical settings with neurological comorbidities such as stroke. The patient’s functional response after only a few sessions indicates an ongoing therapeutic process, with significant clinical advances and an encouraging projection toward greater levels of autonomy and quality of life.